Loading clinical trials...
Loading clinical trials...
Treatment of Refractory Systemic Lupus Erythematosus by Injection of Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord
Conditions
Interventions
mesenchymal stem cells
Locations
1
France
Saint-Louis Hospital
Paris, France
Start Date
September 11, 2019
Primary Completion Date
June 1, 2023
Completion Date
June 1, 2024
Last Updated
July 8, 2021
NCT05436418
NCT07101588
NCT06093867
NCT06647069
NCT04146870
NCT07371468
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions